Search results
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks via Yahoo Finance· 2 years agoPTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoPTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript February 29, 2024 PTC...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Might Not Be As Mispriced As It Looks After Plunging 25%
Simply Wall St. via Yahoo Finance· 12 months agoPTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders won't be pleased to see that the share price has...
PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoPTC Therapeutics (PTCT) delivered earnings and revenue surprises of -11.68% and 11.82%,...
PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
Zacks via Yahoo Finance· 12 months agoPTC Therapeutics' (PTCT) vatiquinone did not achieve its primary endpoint in a late-stage study in...
PTC Therapeutics (PTCT) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 1 year agoPTC Therapeutics (PTCT) might move higher on growing optimism about its earnings prospects, which is...
Is PTC Therapeutics (PTCT) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
GuruFocus.com via Yahoo Finance· 8 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
PTC Therapeutics' Seizure Study Fails To Meet Primary Goal, Analyst Says Minimal Impact On...
Benzinga via Yahoo Finance· 11 months agoPTC Therapeutics Inc (NASDAQ: PTCT) said its MIT-E trial of vatiquinone for mitochondrial...
PTC Therapeutics, Inc.'s (NASDAQ:PTCT) Intrinsic Value Is Potentially 75% Above Its Share Price
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The projected fair value for PTC Therapeutics is US$83.21 based on 2 Stage Free Cash...